Theravance Biopharma, Inc. earnings per share and revenue

TBPH earnings per share for the last quarter are -0.26 USD whereas the estimation was -0.23 USD which accounts for -12.59% surprise. Company revenue for the same period amounts to 16.87 M USD despite the estimated figure of 15.68 M USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 17.07 M USD. Also watch annual changes over time to get a bigger picture of TBPH earnings per share and revenue dynamics.